iRhythm Holdings (IRTC) Cash from Investing Activities (2015 - 2026)
iRhythm Holdings (IRTC) posted quarterly Cash from Investing Activities of $30.2 million for Q1 2026, up 179.22% year-over-year from $10.8 million in Q1 2025, and up 161.92% quarter-over-quarter from -$48.8 million in Q4 2025.
iRhythm Holdings (IRTC) Cash from Investing Activities (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Cash from Investing Activities for 12 consecutive years, with $30.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 179.22% year-over-year to $30.2 million; the TTM figure through Mar 2026 stood at -$208.7 million (down 3.77% YoY), while the FY2025 annual figure was -$277.1 million, down 125.28% from the prior year.
- Cash from Investing Activities advanced to $30.2 million in Q1 2026 per IRTC's latest filing, from -$48.8 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $40.0 million in Q1 2024 and bottomed at -$122.2 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$24.9 million across 5 years, with a median of -$8.5 million in 2022.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 2190.26% — and 2024, when it slumped 8825.64%.
- iRhythm Holdings' Cash from Investing Activities stood at -$8.1 million in 2022, then surged by 117.25% to $1.4 million in 2023, then plunged by 8825.64% to -$122.2 million in 2024, then soared by 60.05% to -$48.8 million in 2025, then soared by 161.92% to $30.2 million in 2026.
- Business Quant data shows IRTC's Cash from Investing Activities at $30.2 million in Q1 2026, -$48.8 million in Q4 2025, and -$89.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | iRhythm Holdings | 4.23 Bn | 3.64 Bn | 163.21 Mn | -48.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -48.64 Mn |
| Jun 30, 2026 | -48.64 Mn |
| Mar 31, 2026 | 30.22 Mn |
| Mar 31, 2026 | 30.22 Mn |
| Dec 31, 2025 | -48.80 Mn |
| Dec 31, 2025 | -48.80 Mn |
| Sep 30, 2025 | -89.20 Mn |
| Sep 30, 2025 | -89.20 Mn |
| Jun 30, 2025 | -100.92 Mn |
| Jun 30, 2025 | -100.92 Mn |
| Mar 31, 2025 | -38.14 Mn |
| Mar 31, 2025 | -38.14 Mn |
| Dec 31, 2024 | -122.16 Mn |
| Dec 31, 2024 | -122.16 Mn |
| Sep 30, 2024 | -55.33 Mn |
| Sep 30, 2024 | -55.33 Mn |
| Jun 30, 2024 | 14.51 Mn |
| Jun 30, 2024 | 14.51 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Mar 31, 2024 | 40.00 Mn |